Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDQuarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2025 | 8 | $0.28 | $0.42 | $0.37 |
Q2 2025 | 5 | $0.41 | $0.45 | $0.43 |
Q3 2025 | 4 | $0.41 | $0.45 | $0.43 |
Q4 2025 | 5 | $0.49 | $0.53 | $0.51 |
Q1 2026 | 3 | $0.46 | $0.50 | $0.48 |
Q2 2026 | 4 | $0.52 | $0.56 | $0.54 |
Q3 2026 | 3 | $0.50 | $0.54 | $0.52 |
Q4 2026 | 4 | $0.59 | $0.65 | $0.62 |
Repligen Corporation last posted its earnings results on Tuesday, November 12th, 2024. The company reported $0.43 earnings per share for the quarter, topping analysts' consensus estimates of $0.3354 by $0.0946. The company had revenue of 154.87 M for the quarter and had revenue of 632.36 M for the year. Repligen Corporation has generated $1 earnings per share over the last year ($0.63 diluted earnings per share) and currently has a price-to-earnings ratio of -453.79. Repligen Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based on prior year's report dates.
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
11/18/2024 | Q3 2024 | $0.32 | $153.02 M | $154.87 M | ||
11/18/2024 | Q2 2024 | $0.06 | $154.11 M | $154.07 M | ||
05/01/2024 | Q1 2024 | $0.29 | $0.04 | -0.25 | $151.35 M | |
02/22/2024 | Q4 2023 | -$0.46 | $155.74 M | |||
10/31/2023 | Q3 2023 | $0.14 | $0.33 | 0.19 | $140.69 M | $141.19 M |
08/02/2023 | Q2 2023 | $0.49 | $0.36 | -0.13 | $165.93 M | $159.17 M |
05/02/2023 | Q1 2023 | $0.59 | $0.52 | -0.07 | $182.66 M | |
02/22/2023 | Q4 2022 | $0.58 | $0.88 | 0.3 | $186.76 M | |
11/01/2022 | Q3 2022 | $0.68 | $0.73 | 0.05 | $191.50 M | $200.74 M |
08/02/2022 | Q2 2022 | $0.72 | $0.90 | 0.18 | $189.06 M | $207.63 M |
04/27/2022 | Q1 2022 | $0.72 | $0.81 | 0.09 | $206.40 M | |
02/17/2022 | Q4 2021 | $0.65 | $0.53 | -0.12 | $186.52 M | |
10/28/2021 | Q3 2021 | $0.64 | $0.61 | -0.03 | $163.91 M | $178.22 M |
07/27/2021 | Q2 2021 | $0.52 | $0.66 | 0.14 | $144.24 M | $162.96 M |
05/04/2021 | Q1 2021 | $0.42 | $0.54 | 0.12 | $142.84 M | |
02/24/2021 | Q4 2020 | $0.31 | $0.37 | 0.06 | $108.65 M | |
11/05/2020 | Q3 2020 | $0.28 | $0.28 | 0 | $86.45 M | $94.06 M |
07/30/2020 | Q2 2020 | $0.28 | $0.30 | 0.02 | $78.38 M | $87.46 M |
05/06/2020 | Q1 2020 | $0.22 | $0.19 | -0.03 | $76.09 M | |
02/26/2020 | Q4 2019 | $0.07 | $69.47 M |
Repligen Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, February 19th, 2025 based off last year's report dates.
In the previous quarter, Repligen Corporation (:RGEN) reported $0.43 earnings per share (EPS) to beat the analysts' consensus estimate of $0.3354 by $0.0946.
The conference call for Repligen Corporation's latest earnings report can be listened to online.
The conference call transcript for Repligen Corporation's latest earnings report can be read online.
Repligen Corporation (:RGEN) has a recorded annual revenue of $632.36 M.
Repligen Corporation (:RGEN) has a recorded net income of $632.36 M. Repligen Corporation has generated $0.64 earnings per share over the last four quarters.
Repligen Corporation (:RGEN) has a price-to-earnings ratio of -453.79 and price/earnings-to-growth ratio is 13.89.
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTED